Summary
Lecithin-cholesterol acyltransferase (LCAT) mass and activity were measured in a Japanese family with familial LCAT deficiency. The two LCAT-deficient subjects had LCAT mass approximately 40–46% of normal (2.65 and 2.31 μg/ml respectively, as compared with normal levels of 5.76±0.95 μg/ml in 19 Japanese subjects) and enzyme activity less than 10% of normal (9.1 and 8.3 nmol/h/ml respectively, as compared with normal levels of 100 nmol/h/ml). All obligate heterozygotes examined, including the father of the two LCAT-deficient subjects, and all five children of the deficient subjects had LCAT mass approximately 72–80% of the normal LCAT mass (4.12, 4.38, 4.45, 4.48, 4.49, 4.61 μg/ml, respectively) and LCAT activity approximately half normal (51.9, 52.4, 54.2, 56.6, and 57.2 nmol/h/ml). We conclude that the two LCAT-deficient subjects of this family have functionally defective enzyme. Furthermore, the data suggest that the plasma of the obligate heterozygotes contain both normal and functionally defective enzymes.
Similar content being viewed by others
References
Albers JJ, Adolphson JL, Chen C-H (1981) Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J Clin Invest 67:141–148
Chen C-H, Albers JJ (1982) Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res 23: 680–691
Albers JJ, Chen C-H, Adolphson JL (1981) Familial lecithincholesterol acyltransferase: Identification of heterozygotes with half-normal enzyme activity. Human Genetics 58:306–309
Albers JJ, Utermann G (1981) Genetic control of lecithin-cholesterol acyltransferase: measurement of LCAT mass in a large kindred with LCAT deficiency. Am J Hum Genet 33:702–708
Utermann C, Menzel HJ, Dieker D, Langer KH, Fiorelli GI (1981) Lecithin: cholesterol acyltransferase deficiency: autosomal recessive transmission in a large kindred. Clin Genet 19:448–455
Albers JJ, Gjone E, Adolphson JL, Chen C-H, Teisberg P, Torsvik P (1981) Familial lecithin-cholesterol acyltransferase (LCATase) in four Norwegian families: Evidence for low levels of a functionally defective enzyme. Acta Medica Scand 210: 455–459
Albers JJ, Wahl PW, Cabana VG, Hazzard WR, Hoover JJ (1976) Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism 25:633–644
Cheung MC, Albers JJ (1977) The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest 60:43–50
Albers JJ, Cheung MC, Ewens SL, Tollefson JH (1981) Characterization and immunoassay of apolipoprotein D. Atherosclerosis 39:395–409
Albers JJ, Cabana VG, Hazzard WR (1979) Immunoassay of human plasma apolipoprotein B. Metabolism 25:1339–1351
Warnick GR, Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65–76
Albers JJ, Bergelin RO, Adolphson JL, Wahl PW (1982) Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). Atherosclerosis 43:369–379
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albers, J.J., Chen, CH., Adolphson, J. et al. Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: Evidence for functionally defective enzyme in homozygotes and obligate heterozygotes. Hum Genet 62, 82–85 (1982). https://doi.org/10.1007/BF00295608
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00295608